Revenue
$10.3B
▲ 6.7% YoY
Net Income
$157.0M
▲ 441.3% YoY
EPS
$0.42
▲ 423.1% YoY
Cash
$1.3B
▲ 10.8% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Lenar Aimee J. President, US Pharma | Sell | Aug 19, 2026 | 36.8K | $7.03 | $259K | Form 4 ↗ |
Lenar Aimee J. President, US Pharma | Sell tax | Jul 17, 2026 | 5.3K | $4.83 | $25K | Form 4 ↗ |
Lenar Aimee J. President, US Pharma | Sell tax | Jul 15, 2026 | 23.4K | $4.89 | $114K | Form 4 ↗ |
LEE STEVEN HYOSIG SVP, Controller & CAO | Sell tax | Jul 14, 2026 | 3.1K | $4.75 | $15K | Form 4 ↗ |
WECHSLER AMY B Director | Grant | Jun 30, 2026 | 1.4K | $4.93 | $7K | Form 4 ↗ |
Paulson John Director | Grant | Jun 30, 2026 | 12.7K | $4.93 | $62K | Form 4 ↗ |
LEUNG SANDRA Director | Grant | Jun 30, 2026 | 6.8K | $4.93 | $34K | Form 4 ↗ |